A multicenter, randomized, parallel groups, placebo-controlled study comparing the efficacy, safety, and tolerability of the daily co-administration of ezetimibe 10 mg or ezetimibe placebo to ongoing treatment with atorvastatin 10 mg in subjects with primary hypercholesterolemia and coronary heart disease.

Trial Profile

A multicenter, randomized, parallel groups, placebo-controlled study comparing the efficacy, safety, and tolerability of the daily co-administration of ezetimibe 10 mg or ezetimibe placebo to ongoing treatment with atorvastatin 10 mg in subjects with primary hypercholesterolemia and coronary heart disease.

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Jun 2014

At a glance

  • Drugs Ezetimibe (Primary)
  • Indications Hypercholesterolaemia
  • Focus Therapeutic Use
  • Sponsors Schering-Plough
  • Most Recent Events

    • 30 Sep 2008 Actual end date (Oct 2006) added as reported by ClinicalTrials.gov.
    • 30 Sep 2008 Actual patient number (81) added as reported by ClinicalTrials.gov.
    • 22 Nov 2006 Status change
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top